ConductScience.org, home

Comparison · NCT02612337-b164b652

OTO-104 (Safety Analysis Set) vs Placebo (Safety Analysis Set): Audiometry - Shift in Air-Bone Gap at 500 Hz From Baseline to Week 12 (Month 3)

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. OTO-104 (Safety Analysis Set) vs Placebo (Safety Analysis Set): Audiometry - Shift in Air-Bone Gap at 500 Hz From Baseline to Week 12 (Month 3). Trial comparisons, record NCT02612337-b164b652. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02612337-b164b652

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.03230.008890.11wilson
Risk in group 20.10.04930.192wilson
Risk difference, group 1 minus group 2-0.0677-0.1630.0252newcombe hybrid score
Risk ratio, group 1 over group 20.3230.06961.5log
Odds ratio, group 1 over group 20.30.05991.5log
Number needed to treat, for one fewer participant with the outcome on OTO-104 (Safety Analysis Set) than on Placebo (Safety Analysis Set)14.8from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: placebo.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1OTO-104 (Safety Analysis Set)All subjects who received OTO-104. Subjects were included in this treatment group according to the actual treatment received regardless of their randomized assignment.262OG000
Group 2Placebo (Safety Analysis Set)All subjects who received Placebo. Subjects were included in this treatment group according to the actual treatment received regardless of their randomized assignment.770OG001

Outcome

Type
SECONDARY
Title
Audiometry - Shift in Air-Bone Gap at 500 Hz From Baseline to Week 12 (Month 3)
Description
The number of subjects with a change in air-bone gap from Baseline to Week 12 (Month 3) from no impairment at baseline (\<= 10 dB) to impairment at Month 3 (\>10 dB) when measured at 500 Hz.
Time frame
3 months
Population
Subjects that had no impairment at the Baseline visit (air-bone gap \<=10 dB)

Source ClinicalTrials.gov

Trial

Title
Study of OTO-104 in Subjects With Unilateral Meniere's Disease
NCT number
NCT02612337
Phases
PHASE3
Conditions
Meniere's Disease
Interventions
OTO-104, Placebo
Lead sponsor
Otonomy, Inc.
Results first posted
2023-01-12

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT02612337-b164b652